96 related articles for article (PubMed ID: 26113559)
1. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
Qin Y; Cui H; Zhang H
Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
[TBL] [Abstract][Full Text] [Related]
2. Retraction: Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Wang XL; Shi WP; Shi HC; Lu SC; Wang K; Sun C; He JS; Jin WG; Lv XX; Zou H; Shu YS
Oncotarget; 2024 May; 15():312. PubMed ID: 38753318
[No Abstract] [Full Text] [Related]
3. Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53.
Lu H; Tan Z; Ko H; Naji P; Zhu R; Wang J; Huang S; Zhang YW; Zeng S
Res Sq; 2024 Jan; ():. PubMed ID: 38260302
[TBL] [Abstract][Full Text] [Related]
4. CRTC1::TRIM11 cutaneous tumor: An update with local recurrence and lung metastasis in a pediatric patient.
Vest BE; Berrebi KG; Stone MS; Sargen MR; Gerami P
J Cutan Pathol; 2024 Mar; 51(3):181-183. PubMed ID: 37944913
[No Abstract] [Full Text] [Related]
5. Advances in the antitumor mechanisms of tripartite motif-containing protein 3.
Teng W; Ling Y; Liu Z; Jiang L; Fu G; Zhou X; Long N; Liu J; Chu L
J Cancer Res Clin Oncol; 2024 Feb; 150(2):105. PubMed ID: 38411731
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism governing RNA-binding property of mammalian TRIM71 protein.
Shi F; Zhang K; Cheng Q; Che S; Zhi S; Yu Z; Liu F; Duan F; Wang Y; Yang N
Sci Bull (Beijing); 2024 Jan; 69(1):72-81. PubMed ID: 38036331
[TBL] [Abstract][Full Text] [Related]
7. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
8. TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling.
Zhu Z; Wang Y; Zhang C; Yu S; Zhu Q; Hou K; Yan B
Sci Rep; 2016 Jan; 6():19070. PubMed ID: 26754079
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
[TBL] [Abstract][Full Text] [Related]
10. The role of Trim25 in development, disease and RNA metabolism.
Heikel G; Choudhury NR; Michlewski G
Biochem Soc Trans; 2016 Aug; 44(4):1045-50. PubMed ID: 27528750
[TBL] [Abstract][Full Text] [Related]
11. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
13. Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation.
Wang Z; Tong D; Han C; Zhao Z; Wang X; Jiang T; Li Q; Liu S; Chen L; Chen Y; Li A; Huang C
EBioMedicine; 2019 Mar; 41():357-369. PubMed ID: 30797711
[TBL] [Abstract][Full Text] [Related]
14. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.
Nasrullah U; Haeussler K; Biyanee A; Wittig I; Pfeilschifter J; Eberhardt W
Cells; 2019 Dec; 8(12):. PubMed ID: 31842382
[TBL] [Abstract][Full Text] [Related]
15. The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development.
Zhang Q; Li X; Cui K; Liu C; Wu M; Prochownik EV; Li Y
Cell Death Differ; 2020 Feb; 27(2):420-433. PubMed ID: 31186535
[TBL] [Abstract][Full Text] [Related]
16. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
17. OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity.
Li F; Sun Q; Liu K; Zhang L; Lin N; You K; Liu M; Kon N; Tian F; Mao Z; Li T; Tong T; Qin J; Gu W; Li D; Zhao W
Nat Commun; 2020 Aug; 11(1):4184. PubMed ID: 32826889
[TBL] [Abstract][Full Text] [Related]
18. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
19. Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway.
Yuan P; Zheng A; Tang Q
Cell Biol Int; 2020 Jul; 44(7):1503-1513. PubMed ID: 32196840
[TBL] [Abstract][Full Text] [Related]
20. TRIM25 in the Regulation of the Antiviral Innate Immunity.
Martín-Vicente M; Medrano LM; Resino S; García-Sastre A; Martínez I
Front Immunol; 2017; 8():1187. PubMed ID: 29018447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]